Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Long-term treatment with cimetidine.

R C Mekel

    South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde
    |December 23, 1978
    PubMed
    Summary
    This summary is machine-generated.

    Cimetidine significantly reduces duodenal ulcer recurrence. In a trial, 80.8% of patients on cimetidine (an H2-receptor antagonist) had no abnormalities after a year, compared to all placebo patients experiencing recurrence.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Prevention of duodenal ulcer relapse with ranitidine.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·1985
    Same author

    Intra-arterial diazepam.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·1982
    Same author

    Ultrastructural changes in gastric ulcers after bicitropeptide and cimetidine treatment.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·1980
    Same author

    Bicitropeptide, antacid and placebo in gastric and duodenal ulceration. A two-centre, double-blind, comparative endoscopic study.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·1979
    Same author

    Letter: Barium meal redundant?

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·1974
    Same author

    Abnormal tryptophan metabolism in patients with scurvy-type skin.

    Biochemical medicine·1973
    Same journal

    SAMA Health Summit Abstracts.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
    Same journal

    On behalf of the South African Medical Association (SAMA), The Scientific Committee of the SAMA Health Summit, is pleased to pesent this abstract issue, showcasing the posters and oral presentations delivered at the Summit, which was held from 22-24 May 2026.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
    Same journal

    Proceedings of the 2<sup>nd</sup> Data Driven Surgery Conference (DDSC 2025).

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
    Same journal

    Clinical practice guidelines for the management of fever and neutropenia in South African children and adolescents with cancer.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
    Same journal

    The changing fortunes of the District Health System in SA (1994 - 2020): A retrospective review.

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
    Same journal

    Thomas Micheal Guntram Ignaz Rehle (1951 - 2025).

    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde·2026
    See all related articles

    Area of Science:

    • Gastroenterology
    • Pharmacology

    Background:

    • Recurrent duodenal ulcers pose a significant clinical challenge.
    • H2-receptor antagonists represent a class of drugs used to manage acid-related gastrointestinal disorders.

    Purpose of the Study:

    • To evaluate the efficacy of cimetidine in preventing duodenal ulcer recurrence.
    • To assess the long-term impact of cimetidine maintenance therapy on duodenal ulceration.

    Main Methods:

    • A double-blind, placebo-controlled trial involving 47 patients.
    • Patients received either 400 mg cimetidine or placebo twice daily.
    • Follow-up included endoscopic evaluation at one year.

    Main Results:

    • Ulcer recurrence was observed in all 14 placebo patients within one year.

    Related Experiment Videos

  • Only 2 out of 26 cimetidine patients experienced ulcer recurrence.
  • 21 out of 26 cimetidine patients (80.8%) showed no endoscopic abnormalities after one year.

    • Conclusions:

    • Maintenance therapy with cimetidine significantly reduces the risk of duodenal ulcer recurrence.
    • Cimetidine is an effective treatment for preventing the progression of duodenal ulcer disease.